<DOC>
	<DOCNO>NCT02894892</DOCNO>
	<brief_summary>Gastric cancer one leading cause cancer-related death worldwide . In Taiwan , around 3800 fresh case annually , 5 % total cancer case . Gastric cancer development know follow multistate process non-atrophic gastritis , atrophic gastritis , intestinal metaplasia , dysplasia , carcinoma ; H. pylorus infection play key role carcinogenic process . Although H. pylori eradication would result marked gastric cancer reduction , treatment success use standard regimen become difficult recent year , increase antibiotic resistance consider important reason decrease treatment efficacy . As specific new medication introduce recent year , novel treatment regimen create use different combination , duration sequence available medication . The addition bismuth improved cure rate despite high prevalence resistance , resistance H. pylorus bismuth report . Bismuth absorption require efficacy H. pylorus treatment regimen , suggest local mechanism action . The mechanisms bismuth responsible rapid destruction H. pylorus within stomach remain unclear . Knowledge mechanism action bismuth compound H. pylorus would beneficial development improve treatment regimens era decline eradication success rate . We conduct pilot study evaluate bacteria fragment H. pylori specimen electron microscopy bismuth therapy provide insight mechanism action pH bismuth therapy . We also help develop optimal H. pylorus therapeutic strategy .</brief_summary>
	<brief_title>Intragastric pH Bismuth Effect H. Pylori Eradication</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Inclusion criterion 1 . Age 2069 2 . Confirmed H. pylorus infection urea breath test previous histology 3 . Scheduled endoscopy 4 . Mentally competent able understand consent form individual equal old 20 5 . Able communicate study staff individual equal old 20 6 . Without history gastric cancer Exclusion criterion 1.History gastric cancer Deferral criterion : 1 . Having receive antibiotic treatment previous 15 day 2 . Need time decide participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Electron Microscopy</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Bismuth</keyword>
</DOC>